1. Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression.
   Sara Franceschi et al, 2018, EBioMedicine CrossRef
2. Kaposi Sarcoma–Associated Herpesvirus and Staphylococcus aureus Coinfection in Oral Cavities of HIV-Positive Patients: A Unique Niche for Oncogenic Virus Lytic Reactivation
   Lu Dai et al, 2019 CrossRef
3. Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
   Shikang Wang et al, 2019, Pharmaceutical Biology CrossRef
4. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer
   Zhuoqi Zhang et al, 2017, Pathology - Research and Practice CrossRef
5. In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met Pathway
   Lu Wang et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Clinico-pathological significance of Drp1dysregulation and its correlation to apoptosis in oral cancer patients
   Aritri Ghosh et al, 2020, Mitochondrion CrossRef
7. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma.
   Christian Bailly, 2020, Chem Biol Interact CrossRef
8. MicroRNA‑25/ATXN3 interaction regulates human colon cancer cell growth and migration
   Dingyun Li et al, 2019, Mol Med Report CrossRef
9. Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis.
   Chao Guo et al, 2020, Cancer Manag Res CrossRef
10. A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
    Haowen Li et al, 2020, Drug Delivery CrossRef
11. Icaritin inhibits lung cancer-induced osteoclastogenesis by suppressing the expression of IL-6 and TNF-a and through AMPK/mTOR signaling pathway.
    Xueqiang Zhao et al, 2020, Anticancer Drugs CrossRef
12. Immobilization of Thermostable β-Glucosidase and α-l-Rhamnosidase from Dictyoglomus thermophilum DSM3960 and Their Cooperated Biotransformation of Total Flavonoids Extract from Epimedium into Icaritin
    Yurong Dong et al, 2021, Catal Lett CrossRef
13. Modification to increase the thermostability and catalytic efficiency of α-L-rhamnosidase from Bacteroides thetaiotaomicron and high-level expression
    Changning Lu et al, 2022, Enzyme and Microbial Technology CrossRef
14. Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime
    Canjing Zhang et al, 2022, Molecular Therapy - Oncolytics CrossRef
15. Linker-peptide-mediated one-step purification and immobilization of α-L-rhamnosidase from Bacteroides thetaiotaomicron for direct biotransformation from epimedin C to icariin
    Changning Lu et al, 2022, Enzyme and Microbial Technology CrossRef
16. PHF6 mutation is associated with poor outcome in acute myeloid leukaemia
    Kexiu Huang et al, 2022, Cancer Medicine CrossRef
17. Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
    Minglu Liu et al, 2022, Front. Pharmacol. CrossRef
18. Icaritin: A phytomolecule with enormous pharmacological values
    Nguyen Thi Huong et al, 2023, Phytochemistry CrossRef
19. Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope
    Mukta Gupta et al, 2023, Phytotherapy Research CrossRef
20. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
    Ka Iong Chan et al, 2024, Aging and disease CrossRef
21. Transplant oncology and anti-cancer immunosuppressants
    Dejun Kong et al, 2025, Front. Immunol. CrossRef
22. Advances in Pharmacological Research on Icaritin: A Comprehensive Review
    Ran Guo et al, 2025, Am. J. Chin. Med. CrossRef